Last 12 months
Inside the activity.
0 purchase rows · 63 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 29 |
| Jan 2026 | 0 | 10 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 45.3486 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000125 · wk-form4_1720558703.xml · derivative · entry 6 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,512.9779 Underlying: Common Shares · 45.3486 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Kobza JoshuaChief Executive Officer
|
GrantPerformance Share Units · Derivative | 1,930.9087 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000125 · wk-form4_1720558703.xml · derivative · entry 5 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,738.578 Underlying: Common Shares · 1,930.9087 shares Expires 2025-02-21 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Kobza JoshuaChief Executive Officer
|
GrantRestricted Share Units · Derivative | 139.5564 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000125 · wk-form4_1720558703.xml · derivative · entry 4 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,965.7307 Underlying: Common Shares · 139.5564 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 443.4418 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000126 · wk-form4_1720558714.xml · derivative · entry 13 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,908.7604 Underlying: Common Shares · 443.4418 shares Expires 2027-03-15 F13 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 111.6543 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000126 · wk-form4_1720558714.xml · derivative · entry 12 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,573.7025 Underlying: Common Shares · 111.6543 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 636.2498 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000126 · wk-form4_1720558714.xml · derivative · entry 11 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,348.2331 Underlying: Common Shares · 636.2498 shares Expires 2026-02-22 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 101.4206 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000126 · wk-form4_1720558714.xml · derivative · entry 10 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,329.6018 Underlying: Common Shares · 101.4206 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 353.4855 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000126 · wk-form4_1720558714.xml · derivative · entry 9 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,972.8623 Underlying: Common Shares · 353.4855 shares Expires 2025-02-25 F9 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 62.265 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000126 · wk-form4_1720558714.xml · derivative · entry 8 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,569.4864 Underlying: Common Shares · 62.265 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 18.1653 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000126 · wk-form4_1720558714.xml · derivative · entry 7 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,208.3427 Underlying: Common Shares · 18.1653 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F7 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F7 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantPerformance Share Units · Derivative | 386.1817 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000126 · wk-form4_1720558714.xml · derivative · entry 6 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,947.7156 Underlying: Common Shares · 386.1817 shares Expires 2025-02-21 F5 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F6 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Schwan AxelPres., Tim Hortons Americas
|
GrantRestricted Share Units · Derivative | 26.2121 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000126 · wk-form4_1720558714.xml · derivative · entry 5 SCHWAN AXEL MR · CIK 0001594977 · Pres., Tim Hortons Americas 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,186.5762 Underlying: Common Shares · 26.2121 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F3 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F4 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F4 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 165.769 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000124 · wk-form4_1720558692.xml · derivative · entry 12 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,148.6899 Underlying: Common Shares · 165.769 shares Expires 2027-03-15 F15 · derivative.exercise_price: The shares reported represent an award of perforamnce based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning Febuary 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be eaned at the end of hte performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 80.306 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000124 · wk-form4_1720558692.xml · derivative · entry 11 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,760.9345 Underlying: Common Shares · 80.306 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 187.7058 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000124 · wk-form4_1720558692.xml · derivative · entry 10 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,815.0384 Underlying: Common Shares · 187.7058 shares Expires 2026-02-22 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 57.487 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000124 · wk-form4_1720558692.xml · derivative · entry 9 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,987.361 Underlying: Common Shares · 57.487 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 218.911 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000124 · wk-form4_1720558692.xml · derivative · entry 8 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,607.9365 Underlying: Common Shares · 218.911 shares Expires 2025-02-25 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 50.2776 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000124 · wk-form4_1720558692.xml · derivative · entry 7 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,111.0798 Underlying: Common Shares · 50.2776 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 25, 2025. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 25, 2025. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 15.5011 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000124 · wk-form4_1720558692.xml · derivative · entry 6 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,884.1097 Underlying: Common Shares · 15.5011 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantPerformance Share Units · Derivative | 241.3812 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000124 · wk-form4_1720558692.xml · derivative · entry 5 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,339.1162 Underlying: Common Shares · 241.3812 shares Expires 2025-02-21 F7 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F8 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:58 UTC |
Fulton DuncanChief Corporate Officer
|
GrantRestricted Share Units · Derivative | 25.403 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000124 · wk-form4_1720558692.xml · derivative · entry 4 Fulton Duncan · CIK 0001908102 · Chief Corporate Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,087.6486 Underlying: Common Shares · 25.403 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F5 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F6 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F6 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 388.0116 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 14 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,170.1653 Underlying: Common Shares · 388.0116 shares Expires 2027-03-15 F15 · derivative.exercise_price: The shares reported represent an award of performance based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 116.4929 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 13 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,161.9199 Underlying: Common Shares · 116.4929 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F14 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. F14 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 318.1249 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 12 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,674.1165 Underlying: Common Shares · 318.1249 shares Expires 2026-02-22 F13 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 57.5556 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 11 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,996.9757 Underlying: Common Shares · 57.5556 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F12 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F12 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 353.4855 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 10 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,972.8623 Underlying: Common Shares · 353.4855 shares Expires 2025-02-25 F11 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending December 31, 2024 and to the extent earned will vest on February 25, 2025. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 38.741 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 9 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,709.7092 Underlying: Common Shares · 38.741 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F10 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F10 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 23.7761 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 8 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,890.4302 Underlying: Common Shares · 23.7761 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 186.7931 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 7 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,708.2394 Underlying: Common Shares · 186.7931 shares Expires 2025-02-21 F8 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020-2 PBRSUs") granted to the Reporting Person. The 2020-2 PBRSUs will have a performance period beginning January 1, 2021 and ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantPerformance Share Units · Derivative | 193.0909 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 6 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,473.8578 Underlying: Common Shares · 193.0909 shares Expires 2025-02-21 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units (the "2020-1 PBRSUs") granted to the Reporting Person. The 2020-1 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| July 05, 2024 Filed Jul 9, 2024 20:57 UTC |
Siddiqui Sami A.Chief Financial Officer
|
GrantRestricted Share Units · Derivative | 69.1555 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000122 · wk-form4_1720558670.xml · derivative · entry 5 Siddiqui Sami A. · CIK 0001829353 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,407.1622 Underlying: Common Shares · 69.1555 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
| May 06, 2024 Filed May 8, 2024 23:52 UTC |
Kobza JoshuaChief Executive Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $42.26 | $0.00 |
DisclosureSEC source: 0001618756-24-000087 · wk-form4_1715212368.xml · derivative · entry 7 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 300,000 shares Expires 2025-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person exercised these options in advance of the upcoming expiration in March 2025 in order to retain ownership of all shares, less those required to be sold to pay the exercise price and applicable taxes. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 06, 2024 Filed May 8, 2024 23:52 UTC |
Kobza JoshuaChief Executive Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 35,494 | $0.00 Strike: $42.26 | $0.00 |
DisclosureSEC source: 0001618756-24-000087 · wk-form4_1715212368.xml · derivative · entry 6 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 35,494 shares Expires 2025-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person exercised these options in advance of the upcoming expiration in March 2025 in order to retain ownership of all shares, less those required to be sold to pay the exercise price and applicable taxes. F5 · derivative.exercise_date: These options are fully vested and exercisable. Read SEC document |
| May 06, 2024 Filed May 8, 2024 23:52 UTC |
Kobza JoshuaChief Executive Officer
|
SaleCommon Shares | 220,165 | $75.14 | $16,543,198.10 |
DisclosureSEC source: 0001618756-24-000087 · wk-form4_1715212368.xml · nonDerivative · entry 4 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 675,598.7362 F1 · kind: The reporting person exercised these options in advance of the upcoming expiration in March 2025 in order to retain ownership of all shares, less those required to be sold to pay the exercise price and applicable taxes. F3 · price: Represents the weighted average price of the share sold. The prices of the shares sold pursuant to the transaction ranged from $75.00 to $75.41 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price. Read SEC document |
| May 06, 2024 Filed May 8, 2024 23:52 UTC |
Kobza JoshuaChief Executive Officer
|
Exercise / conversionCommon Shares | 300,000 | $42.26 | $12,678,000.00 |
DisclosureSEC source: 0001618756-24-000087 · wk-form4_1715212368.xml · nonDerivative · entry 3 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 895,763.7362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person exercised these options in advance of the upcoming expiration in March 2025 in order to retain ownership of all shares, less those required to be sold to pay the exercise price and applicable taxes. Read SEC document |
| May 06, 2024 Filed May 8, 2024 23:52 UTC |
Kobza JoshuaChief Executive Officer
|
SaleCommon Shares | 26,031 | $75.47 | $1,964,559.57 |
DisclosureSEC source: 0001618756-24-000087 · wk-form4_1715212368.xml · nonDerivative · entry 2 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 595,763.7362 F1 · kind: The reporting person exercised these options in advance of the upcoming expiration in March 2025 in order to retain ownership of all shares, less those required to be sold to pay the exercise price and applicable taxes. F2 · price: Represents the weighted average price of the share sold. The prices of the shares sold pursuant to the transaction ranged from $75.28 to $75.64 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each price. Read SEC document |
| May 06, 2024 Filed May 8, 2024 23:52 UTC |
Kobza JoshuaChief Executive Officer
|
Exercise / conversionCommon Shares | 35,494 | $42.26 | $1,499,976.44 |
DisclosureSEC source: 0001618756-24-000087 · wk-form4_1715212368.xml · nonDerivative · entry 1 Kobza Joshua · CIK 0001574771 · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 621,794.7362 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person exercised these options in advance of the upcoming expiration in March 2025 in order to retain ownership of all shares, less those required to be sold to pay the exercise price and applicable taxes. Read SEC document |
| May 03, 2024 Filed May 8, 2024 00:26 UTC |
Hedayat AliDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 11,381 | $0.00 Strike: $46.77 | $0.00 |
DisclosureSEC source: 0001618756-24-000085 · wk-form4_1715127951.xml · derivative · entry 3 Hedayat Ali · CIK 0001679916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 11,381 shares Expires 2026-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: The options were issued with an exercise price of CAD $61.65. The reported exercise price represents the U.S. dollar equivalent. F1 · kind: The reporting person exercised these options in order to retain ownership of all shares, less those required to be sold to pay the exercise price and applicable taxes. F4 · derivative.exercise_date: These options are immediately exercisable. Read SEC document |
| May 03, 2024 Filed May 8, 2024 00:26 UTC |
Hedayat AliDirector
|
SaleCommon Shares | 8,537 | $74.75 | $638,140.75 |
DisclosureSEC source: 0001618756-24-000085 · wk-form4_1715127951.xml · nonDerivative · entry 2 Hedayat Ali · CIK 0001679916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,881 F1 · kind: The reporting person exercised these options in order to retain ownership of all shares, less those required to be sold to pay the exercise price and applicable taxes. F3 · price: The reported shares were sold in Canadian dollars and converted into their U.S. dollar equivalent using the Bank of Canada daily exchange rate on May 3, 2024 of 0.7314. Read SEC document |
| May 03, 2024 Filed May 8, 2024 00:26 UTC |
Hedayat AliDirector
|
Exercise / conversionCommon Shares | 11,381 | $46.77 | $532,289.37 |
DisclosureSEC source: 0001618756-24-000085 · wk-form4_1715127951.xml · nonDerivative · entry 1 Hedayat Ali · CIK 0001679916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,418 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person exercised these options in order to retain ownership of all shares, less those required to be sold to pay the exercise price and applicable taxes. F2 · price: The options were issued with an exercise price of CAD $61.65. The reported exercise price represents the U.S. dollar equivalent. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 200.6592 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 15 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,732.6592 Underlying: Common Shares · 200.6592 shares Expires 2027-03-15 F14 · derivative.exercise_price: The shares reported represent an award of perforamnce based share units ("2024 PSUs") granted to the Reporting Person. The 2024 PSUs will have a performance period beginning February 23, 2024 and ending February 23, 2027 and to the extent earned will vest on March 15, 2027. The number of common shares that will be eaned at the end of hte performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 75.1375 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 14 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,010.1375 Underlying: Common Shares · 75.1375 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F13 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. F13 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2024, December 15, 2025, December 15, 2026 and December 15, 2027. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 172.7434 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 13 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,013.5949 Underlying: Common Shares · 172.7434 shares Expires 2026-02-22 F12 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2023 PBRSUs") granted to the Reporting Person. The 2023 PBRSUs will have a performance period beginning January 1, 2023 and ending December 31, 2025 and to the extent earned will vest on February 22, 2026, the number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 54.6396 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 12 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,279.3227 Underlying: Common Shares · 54.6396 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F11 · derivative.exercise_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. F11 · derivative.expiration_date: These restricted share units vest in equal installments on December 15, 2023, December 15, 2024, December 15, 2025 and December 15, 2026. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 199.941 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 11 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,636.9768 Underlying: Common Shares · 199.941 shares Expires 2025-02-25 F10 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2022 PBRSUs") granted to the Reporting Person. The 2022 PBRSUs will have a performance period beginning January 1, 2022 and ending on December 31, 2024 and to the extent earned will vest on February 25, 2025, which has been selected as the vesting date of the grant. The number of common shares that will be earned at the end of the performance period is subject to increase or decrease based on the results of the performance condition. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 48.0954 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 10 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,407.4718 Underlying: Common Shares · 48.0954 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F9 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. F9 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2022, December 31, 2023, December 31, 2024 and December 31, 2025. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 9.1416 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 9 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,217.8815 Underlying: Common Shares · 9.1416 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 52.3693 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 8 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,976.8648 Underlying: Common Shares · 52.3693 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F8 · derivative.exercise_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. F8 · derivative.expiration_date: These restricted share units vest in equal installments on December 31, 2021, December 31, 2022, December 31, 2023 and December 31, 2024. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantPerformance Share Units · Derivative | 174.7488 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 7 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,280.7669 Underlying: Common Shares · 174.7488 shares Expires 2025-02-21 F6 · derivative.exercise_price: The shares reported represent an award of performance based restricted share units ("2020 PBRSUs") granted to the Reporting Person. The 2020 PBRSUs have a performance period ending December 31, 2021 and will vest on February 21, 2025, which is the fifth anniversary of the grant date. F7 · shares: Represents dividend equivalent rights that accrued on the underlying award of performance based restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable performance based restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. Read SEC document |
| April 04, 2024 Filed Apr 9, 2024 00:08 UTC |
Housman JeffreySee Remarks
|
GrantRestricted Share Units · Derivative | 21.4591 | $0.00 | $0.00 |
DisclosureSEC source: 0001618756-24-000062 · wk-form4_1712621294.xml · derivative · entry 6 Housman Jeffrey · CIK 0001908101 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,858.8781 Underlying: Common Shares · 21.4591 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share. F4 · shares: Represents dividend equivalent rights that accrued on the underlying award of restricted share units. Dividend equivalent rights accrue when and as dividends are paid on the common shares underlying the applicable restricted share units and vest proportionately with and are subject to settlement and expiration upon the same terms as the restricted share units to which they relate. F5 · derivative.exercise_date: These restricted share units vest on December 31, 2024. F5 · derivative.expiration_date: These restricted share units vest on December 31, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.